Strides Pharma Science Ltd

STAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,771 cr, stock is ranked 645
Moderate RiskStock is 2.50x as volatile as Nifty
291.0017.65 (-5.72%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,771 cr, stock is ranked 645
Moderate RiskStock is 2.50x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
10.33
PB RatioPB Ratio
0.99
Dividend YieldDiv. Yield
0.81%
Sector PESector PE
33.47
Sector PBSector PB
4.80
Sector Div YldSctr Div Yld
0.85%

Forecast & RatingsDetailed Forecast 

75%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020213.532.552.913.520.660.320.040.27
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.00%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 2.46%

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnMay 15, 2022

Strides Pharma Science Limited has informed the Exchange about press release dated 15-May-2022 titled Clarification on news item appeared online based on a report filed by Press Trust of India (PTI) titled ¬タワUnable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs.¬タン | Download

Strides Pharma Science Limited has informed the Exchange about press release dated 15-May-2022 titled Clarification on news item appeared online based on a report filed by Press Trust of India (PTI) titled ¬タワUnable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs.¬タン | Download

Loss of share certificate 
Announced OnMay 13, 2022

Strides Pharma Science Limited has informed the Exchange about issuance of ¬タリLetter of Confirmation¬タル (LoC) | Download

Strides Pharma Science Limited has informed the Exchange about issuance of ¬タリLetter of Confirmation¬タル (LoC) | Download

Cash Dividend 
Ex. DateAug 5, 2021

Final • Div/Share: ₹ 2.5

See all events